Clik here to view.
Resolution in Florida Wrongful Birth Case
Tom Clarkson is a student at the University of Georgia School of Law. The “Wrongful Birth” debate is in the news yet again. In a pair of previous posts (here and here) the Genomics Law Report...
View ArticleClik here to view.
The Genomics and Personalized Medicine Act Returns to Congress
Meggan Bushee is a student at the Wake Forest University School of Law. This past May, Congressman Patrick Kennedy (D-RI) and Congresswoman Anna Eshoo (D-CA) re-introduced a personalized medicine bill...
View ArticleClik here to view.
The Cost of Regulating LDTs
Jeffrey N. Gibbs is a director at the law firm of Hyman, Phelps & McNamara and specializes in FDA-related matters. For many years, the Food and Drug Administration (FDA) has taken the position that...
View ArticleRestricting Gene Patents: A Pro-Market Agenda
This commentary is contributed by James P. Evans, clinical professor genetics and medicine at the University of North Carolina and Editor-in-Chief of Genetics in Medicine. Gene patents have been...
View ArticleClik here to view.
How Will Myriad Respond to the Next Generation of BRCA Testing?
Robert Cook-Deegan contributed to this commentary. Dr. Cook-Deegan is Director of the Center for Genome Ethics, Law & Policy at Duke University Institute for Genome Sciences and Policy’s and is...
View ArticleClik here to view.
DTC Genetic Testing and the FDA: is there an end in sight to the regulatory...
Editor’s Note: This was first published at Genomes Unzipped and was co-authored by Daniel MacArthur and Luke Jostins. Genomes Unzipped received 12 free kits from Lumigenix for review purposes, and Dan...
View ArticleClik here to view.
Don’t Forget About State Law: Michigan Decision Reminds Health Care Providers...
Phillip C. Ross is a summer associate at Robinson, Bradshaw & Hinson, P.A. and a rising third-year student at Wake Forest University School of Law. Many health care providers and other individuals...
View ArticleClik here to view.
Removing the Cables: New FCC Rule Paves Way for Utilization of Wireless...
Amit Bhagwandass is a rising third-year student at University of North Carolina School of Law. New rules adopted by the Federal Communications Commission (FCC) have an appreciable impact on the way...
View ArticleClik here to view.
ENCODE, CODIS, and the Urgent Need to Focus on what is Scientifically and...
Sara Huston Katsanis, MS is an Associate in Research at the Institute for Genome Sciences & Policy at Duke University. On September 5, 2012, a coordinated release of 30 articles in Nature, Cell,...
View ArticleClik here to view.
Supreme Court to Rule on Patentability of Human Genes
Robert Cook-Deegan contributed to this commentary. Dr. Cook-Deegan is a research professor in the Institute for Genome Sciences and Policy and the Sanford School of Public Policy at Duke University....
View ArticleClik here to view.
Australian appeals court upholds patents on isolated BRCA1 DNA
Robert Cook-Deegan, MD On September 5, the Federal Court of Australia (the appeals court) upheld a claim on isolated DNA from the BRCA1 gene. It dismissed Yvonne D’Arcy’s appeal of a case that has...
View ArticleClik here to view.
Williams v. Athena Motion to Dismiss Hearing—SC Supreme Court May Be Asked to...
Foreword by John Conley Back on May 31, 2016, Contributing Editor Jennifer Wagner wrote a lengthy report on the newly filed case of Williams v. Quest Diagnostics, et al. As Jen recounted, plaintiff...
View ArticleClik here to view.
The Genomics and Personalized Medicine Act Returns to Congress
Meggan Bushee is a student at the Wake Forest University School of Law. This past May, Congressman Patrick Kennedy (D-RI) and Congresswoman Anna Eshoo (D-CA) re-introduced a personalized medicine bill...
View ArticleClik here to view.
The Cost of Regulating LDTs
Jeffrey N. Gibbs is a director at the law firm of Hyman, Phelps & McNamara and specializes in FDA-related matters. For many years, the Food and Drug Administration (FDA) has taken the position that...
View ArticleRestricting Gene Patents: A Pro-Market Agenda
This commentary is contributed by James P. Evans, clinical professor genetics and medicine at the University of North Carolina and Editor-in-Chief of Genetics in Medicine. Gene patents have been...
View ArticleClik here to view.
How Will Myriad Respond to the Next Generation of BRCA Testing?
Robert Cook-Deegan contributed to this commentary. Dr. Cook-Deegan is Director of the Center for Genome Ethics, Law & Policy at Duke University Institute for Genome Sciences and Policy’s and is...
View ArticleClik here to view.
DTC Genetic Testing and the FDA: is there an end in sight to the regulatory...
Editor’s Note: This was first published at Genomes Unzipped and was co-authored by Daniel MacArthur and Luke Jostins. Genomes Unzipped received 12 free kits from Lumigenix for review purposes, and Dan...
View ArticleClik here to view.
Don’t Forget About State Law: Michigan Decision Reminds Health Care Providers...
Phillip C. Ross is a summer associate at Robinson, Bradshaw & Hinson, P.A. and a rising third-year student at Wake Forest University School of Law. Many health care providers and other individuals...
View ArticleClik here to view.
Removing the Cables: New FCC Rule Paves Way for Utilization of Wireless...
Amit Bhagwandass is a rising third-year student at University of North Carolina School of Law. New rules adopted by the Federal Communications Commission (FCC) have an appreciable impact on the way...
View ArticleClik here to view.
ENCODE, CODIS, and the Urgent Need to Focus on what is Scientifically and...
Sara Huston Katsanis, MS is an Associate in Research at the Institute for Genome Sciences & Policy at Duke University. On September 5, 2012, a coordinated release of 30 articles in Nature, Cell,...
View Article
